Logo image of BHLB

BERKSHIRE HILLS BANCORP INC (BHLB) Stock Fundamental Analysis

USA - NYSE:BHLB - US0846801076 - Common Stock

26.13 USD
-0.17 (-0.65%)
Last: 8/29/2025, 8:08:14 PM
26.13 USD
0 (0%)
After Hours: 8/29/2025, 8:08:14 PM
Fundamental Rating

5

BHLB gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 392 industry peers in the Banks industry. BHLB has a bad profitability rating. Also its financial health evaluation is rather negative. BHLB is growing strongly while it also seems undervalued. This is an interesting combination


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

BHLB had positive earnings in the past year.
BHLB had a positive operating cash flow in the past year.
BHLB had positive earnings in 4 of the past 5 years.
BHLB had a positive operating cash flow in each of the past 5 years.
BHLB Yearly Net Income VS EBIT VS OCF VS FCFBHLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

BHLB has a Return On Assets (0.94%) which is comparable to the rest of the industry.
With a Return On Equity value of 9.27%, BHLB perfoms like the industry average, outperforming 58.59% of the companies in the same industry.
Industry RankSector Rank
ROA 0.94%
ROE 9.27%
ROIC N/A
ROA(3y)0.62%
ROA(5y)-0.26%
ROE(3y)7.27%
ROE(5y)-2.61%
ROIC(3y)N/A
ROIC(5y)N/A
BHLB Yearly ROA, ROE, ROICBHLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

With a Profit Margin value of 24.62%, BHLB perfoms like the industry average, outperforming 55.05% of the companies in the same industry.
BHLB's Profit Margin has declined in the last couple of years.
BHLB does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 24.62%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-17.67%
PM growth 5Y-6.62%
GM growth 3YN/A
GM growth 5YN/A
BHLB Yearly Profit, Operating, Gross MarginsBHLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

3

2. Health

2.1 Basic Checks

BHLB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BHLB has more shares outstanding
Compared to 5 years ago, BHLB has less shares outstanding
BHLB has a better debt/assets ratio than last year.
BHLB Yearly Shares OutstandingBHLB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BHLB Yearly Total Debt VS Total AssetsBHLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

BHLB has a debt to FCF ratio of 0.90. This is a very positive value and a sign of high solvency as it would only need 0.90 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.90, BHLB is in the better half of the industry, outperforming 73.48% of the companies in the same industry.
A Debt/Equity ratio of 0.10 indicates that BHLB is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.10, BHLB is in the better half of the industry, outperforming 69.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.9
Altman-Z N/A
ROIC/WACCN/A
WACC7.99%
BHLB Yearly LT Debt VS Equity VS FCFBHLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BHLB Yearly Current Assets VS Current LiabilitesBHLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

7

3. Growth

3.1 Past

BHLB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.08%, which is quite impressive.
The Earnings Per Share has been decreasing by -1.63% on average over the past years.
Looking at the last year, BHLB shows a very strong growth in Revenue. The Revenue has grown by 30.64%.
The Revenue has been decreasing by -2.30% on average over the past years.
EPS 1Y (TTM)21.08%
EPS 3Y-2.83%
EPS 5Y-1.63%
EPS Q2Q%25.45%
Revenue 1Y (TTM)30.64%
Revenue growth 3Y-2.71%
Revenue growth 5Y-2.3%
Sales Q2Q%3.83%

3.2 Future

The Earnings Per Share is expected to grow by 30.09% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 56.15% on average over the next years. This is a very strong growth
EPS Next Y23.59%
EPS Next 2Y30.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year36.1%
Revenue Next 2Y56.15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BHLB Yearly Revenue VS EstimatesBHLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
BHLB Yearly EPS VS EstimatesBHLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -5 -10

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.58 indicates a reasonable valuation of BHLB.
Based on the Price/Earnings ratio, BHLB is valued a bit cheaper than 77.78% of the companies in the same industry.
BHLB is valuated cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 6.96 indicates a rather cheap valuation of BHLB.
90.91% of the companies in the same industry are more expensive than BHLB, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.86. BHLB is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.58
Fwd PE 6.96
BHLB Price Earnings VS Forward Price EarningsBHLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

BHLB's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BHLB is cheaper than 77.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.93
EV/EBITDA N/A
BHLB Per share dataBHLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

BHLB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BHLB's earnings are expected to grow with 30.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.45
PEG (5Y)N/A
EPS Next 2Y30.09%
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

BHLB has a Yearly Dividend Yield of 2.76%.
Compared to an average industry Dividend Yield of 3.73, BHLB has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, BHLB has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.76%

5.2 History

The dividend of BHLB decreases each year by -6.24%.
BHLB has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of BHLB decreased in the last 3 years.
Dividend Growth(5Y)-6.24%
Div Incr Years0
Div Non Decr Years2
BHLB Yearly Dividends per shareBHLB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

28.33% of the earnings are spent on dividend by BHLB. This is a low number and sustainable payout ratio.
DP28.33%
EPS Next 2Y30.09%
EPS Next 3YN/A
BHLB Yearly Income VS Free CF VS DividendBHLB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M
BHLB Dividend Payout.BHLB Dividend Payout, showing the Payout Ratio.BHLB Dividend Payout.PayoutRetained Earnings

More info and screens

BERKSHIRE HILLS BANCORP INC

NYSE:BHLB (8/29/2025, 8:08:14 PM)

After market: 26.13 0 (0%)

26.13

-0.17 (-0.65%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-24 2025-07-24/bmo
Earnings (Next)10-22 2025-10-22/bmo
Inst Owners95.14%
Inst Owner Change3.98%
Ins Owners0.87%
Ins Owner Change-0.04%
Market Cap1.21B
Analysts76.67
Price Target32.29 (23.57%)
Short Float %5.59%
Short Ratio5.09
Dividend
Industry RankSector Rank
Dividend Yield 2.76%
Yearly Dividend0.69
Dividend Growth(5Y)-6.24%
DP28.33%
Div Incr Years0
Div Non Decr Years2
Ex-Date08-14 2025-08-14 (0.18)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.24%
Min EPS beat(2)10.47%
Max EPS beat(2)14.01%
EPS beat(4)4
Avg EPS beat(4)9.1%
Min EPS beat(4)3.8%
Max EPS beat(4)14.01%
EPS beat(8)7
Avg EPS beat(8)5.56%
EPS beat(12)8
Avg EPS beat(12)0.97%
EPS beat(16)11
Avg EPS beat(16)1.94%
Revenue beat(2)0
Avg Revenue beat(2)-3.39%
Min Revenue beat(2)-4.28%
Max Revenue beat(2)-2.51%
Revenue beat(4)0
Avg Revenue beat(4)-3.47%
Min Revenue beat(4)-4.58%
Max Revenue beat(4)-2.5%
Revenue beat(8)0
Avg Revenue beat(8)-4.47%
Revenue beat(12)3
Avg Revenue beat(12)0.91%
Revenue beat(16)7
Avg Revenue beat(16)11.93%
PT rev (1m)0%
PT rev (3m)-0.78%
EPS NQ rev (1m)0.43%
EPS NQ rev (3m)4.33%
EPS NY rev (1m)3.46%
EPS NY rev (3m)3.46%
Revenue NQ rev (1m)-2.29%
Revenue NQ rev (3m)-2.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.41%
Valuation
Industry RankSector Rank
PE 10.58
Fwd PE 6.96
P/S 2.64
P/FCF 8.93
P/OCF 8.34
P/B 0.99
P/tB 1
EV/EBITDA N/A
EPS(TTM)2.47
EY9.45%
EPS(NY)3.76
Fwd EY14.38%
FCF(TTM)2.93
FCFY11.2%
OCF(TTM)3.13
OCFY11.99%
SpS9.91
BVpS26.35
TBVpS26.07
PEG (NY)0.45
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.94%
ROE 9.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 24.62%
GM N/A
FCFM 29.52%
ROA(3y)0.62%
ROA(5y)-0.26%
ROE(3y)7.27%
ROE(5y)-2.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-17.67%
PM growth 5Y-6.62%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.9
Debt/EBITDA N/A
Cap/Depr 89.7%
Cap/Sales 2.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 119.89%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC7.99%
ROIC/WACCN/A
Cap/Depr(3y)21.12%
Cap/Depr(5y)22.6%
Cap/Sales(3y)0.65%
Cap/Sales(5y)0.84%
Profit Quality(3y)184.17%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.08%
EPS 3Y-2.83%
EPS 5Y-1.63%
EPS Q2Q%25.45%
EPS Next Y23.59%
EPS Next 2Y30.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.64%
Revenue growth 3Y-2.71%
Revenue growth 5Y-2.3%
Sales Q2Q%3.83%
Revenue Next Year36.1%
Revenue Next 2Y56.15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-19.38%
FCF growth 3Y5.1%
FCF growth 5Y3.64%
OCF growth 1Y-14.49%
OCF growth 3Y5.87%
OCF growth 5Y2.35%